TPST Tempest Tx: Bozor kapitallashuvining balans qiymatiga nisbati

Tempest Tx (TPST) - korporativ logo

Tempest Therapeutics (TPST) o'zining onkologiya patentlaridan noyob formulalarni litsenziyalash huquqini korporativ gigantlarga berish orqali pul ishlab topadi. ​​Shu bilan birga, kompaniya aralashma ishlab chiqarish va sinovlarni to'liq tashqi pudratchilarga topshiradi, bu esa uchinchi tomon imkoniyatlariga katta bog'liqlikni yaratadi. GURU.Markets saytidagi ushbu kundalik narx jadvali, bu yerda indikator -7.42 ga teng, klinik bosqichlar bilan bog'liq xavflarga qaramay, TPST-1120 ning muvaffaqiyatidan keyin raqobatbardoshlikning oshishini tasdiqlaydi.

Tempest Therapeutics (TPST) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

TPST (Tempest Therapeutics Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Tempest Therapeutics|TPST - Tahlilchilarning prognoz narxlari
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Tempest Tx|TPST - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Tempest Therapeutics|TPST - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati tempesttx.com|TPST - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Tempest Therapeutics|TPST - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Tempest Tx|TPST - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Tempest Tx
Fundamental baholash:TPST (Tempest Therapeutics)
Tempest Therapeutics Inc tayyor mahsulotlari

Tempest Therapeutics (TPST) rivojlanishi barqaror daromad yo'qligida uning R&D loyihalari muvaffaqiyatiga kritik darajada bog'liqdir. Ushbu ko'rsatkich kompaniyaning joriy bozor qiymatini uning haqiqiy kapitali bilan solishtiradi. U aktivlarning haddan tashqari qimmat baholanganlik darajasini yoki bozor skeptitsizmi darajasini namoyish etadi. Investor uchun bu spekulyativ kutishlar va haqiqiy likvidlik rezervlari o'rtasidagi muvozanatning belgisi bo'lib xizmat qiladi. Kitob qiymatiga nisbatan bozor baholashining tarixi ushbu tebranishlarni aniq aks ettiradi.

Asosiy raqobatchilar

ONC - Kapitallashuvning sof aktivlarga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA (XBIT)|Kapitallashuvning sof aktivlarga nisbati CEL-SCI Corporation|Bozor kapitallashuvining balans qiymatiga multiplikatori ostherapies.com (OSTX)|RADX: Bozor kapitallashuvining balans qiymatiga nisbati|Artiva Biotherapeutics Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|ANL: Bozor qiymatining balans qiymatiga nisbati|VERU: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati xiliotx.com (XLO)|Renovaro (RENB) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati MURA (Mural Oncology PLC)|Bozor qiymatining balans qiymatiga koeffitsiyenti KAPA|OKUR (OnKure Therapeutics Inc) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi w2.cytomed.sg GDTC|Kapitallashuvning sof aktivlarga nisbati Curis (CRIS)|APLM - Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati Tharimmune (THAR)|Advanced Biomed Inc (ADVB) - Balans qiymatiga nisbatan bozor qiymati|GNPX - Kapitallashuvning sof aktivlarga nisbati|Calidi Biotherapeutics, Inc. (CLDI) - Bozor kapitallashuvining balans qiymatiga multiplikatori|SBFM - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Xenetic Bio|Salarius Pharmaceuticals, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti PPBT (Purple Biotech Ltd)|Bozor qiymatining balans qiymatiga nisbati American Oncology Network, Inc.|Balans qiymatiga nisbatan bozor qiymati BeiGene Ltd BGNE|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ELEV: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati icadmed.com (ICAD)|Ikena Oncology (IKNA) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati NTBL (Notable Labs Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Viracta (VIRX)|Kapitallashuvning sof aktivlarga nisbati MOR|Bozor kapitallashuvining balans qiymatiga nisbati nayabiosciences.com NAYA|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma (AAPGV)